3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gynecologic
2
Conditions
Ovarian Neoplasms
799
Uterine Cervical Neoplasms
537
Endometrial Neoplasms
459
Breast Neoplasms
221
Fallopian Tube Neoplasms
198
Colorectal Neoplasms
179
Carcinoma, Non-Small-Cell Lung
163
Neoplasms
137
Stomach Neoplasms
127
Pancreatic Neoplasms
118
Prostatic Neoplasms
107
Neoplasm Metastasis
107
Melanoma
107
Lung Neoplasms
103
Carcinoma, Ovarian Epithelial
92
Triple Negative Breast Neoplasms
91
Squamous Cell Carcinoma of Head and Neck
82
Esophageal Neoplasms
77
Head and Neck Neoplasms
75
Carcinoma, Renal Cell
75
Urinary Bladder Neoplasms
74
Uterine Neoplasms
66
Vulvar Neoplasms
64
Colonic Neoplasms
59
Peritoneal Neoplasms
58
Carcinoma, Hepatocellular
58
Uterine Cervical Dysplasia
57
Sarcoma
52
Carcinoma, Transitional Cell
48
Papillomavirus Infections
47
Interventions
Naproxen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Dysmenorrhea
×
Gynecologic
×
1 year
×
Clear all
NCT07397715
2026-02-12
MUSA3
Swiss GO Trial Group
Recruiting
1,000 enrolled
NCT04145518
2025-12-12
MCUP
Endeavor Health
Phase 4
Completed
183 enrolled